Articles On Acrux (ASX:ACR)

2021 is set to be another big year for ASX capital raisings with solid volumes so far in 2021. In the first nine weeks of the new year, ASX companies have raised over $1.96 billion. Although this is lower than the $3 billion raised in the f...

The FDA has notified Acrux that its Abbreviated New Drug Application submission has been approved and that Acrux can manufacture and market the generic drug.

Summary Drug development company Acrux Limited has got the green light from the US FDA for its generic product, equivalent to Testosterone Topical Solution from Perrigo. The Company can now produce and market the generic drug. The top...

The Acrux Limited (ASX: ACR) share price is soaring today, up 36.36% at the time of writing to 22 cents a share. Acrux shares closed at 16 cents a share yesterday but opened at 28 cents a share this morning before soaring all the way up to...

When it comes to biotech stocks, the ultimate goal is always to get a drug to market. Acrux today shared the good news that their testosterone topic solution has been approved by the US Food & Drug Administration (FDA)... The post Acrux...

Pharmaceutical company Acrux (ASX: ACR) has secured United Stated Food and Drug Administration approval for its generic testosterone topical solution. The topical drug is based on Perrigo’s Testosterone Topical solution which has a dose of...

ShareCafeAustralia…One Hour In…ASX up 10 points ASX200 up 10 points (0.1%) to 6707. Acrux (+48%); the USFDA has approved its generic product based on Perrigo’s Testosterone Topical Solution. Altium (-3.7%);  1H revenue fell by 3% on the im...

Jobkeeper subsidies will make up two thirds of dental group 1300 Smiles’ (ASX:ONT) final dividend at 12.5c payout. The company has maintained its fully franked final dividend at 12.5c, paying out a total of $2.96m to investors. The company...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Believe it or not, there are a handful of shares that you can still buy today on the ASX that are exempt from tax when you finally sell them. I’m talking about ASX-listed pooled development fund (PDF) companies, which, despite their attrac...

Another day, another biotech winner. The Acrux Ltd [ASX:ACR] share price is up 33.33% at time of writing. Surging on the back of confirmation of a new deal in the US. They’ve joined forces with private company TruPharma... The post Acrux Sh...

A quick wrap of the key winners and losers on Friday, May 29. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Code Name Price % Chg Volume VA...

The Acrux Limited (ASX: ACR) share price has taken off this morning, bolting out of the gates to be up by as much as 62.96% in early trade. At the time of writing, Acrux shares are still sitting 40.74% higher at 19 cents per share, taking...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

You don’t need a PhD to run a biotech, but sometimes it helps, as these companies deal in one of the most complicated mysteries still to be solved today: the human body. Biotech CEOs and chairs tend to be the cross-over scientists. However,...

The 10th Annual Australian Microcap Investment Conference will be held on Tuesday 22 October 2019 over two days at the Sofitel Melbourne on Collins. The Conference is Australia’s largest and most comprehensive emerging company investment ev...

FirstWave Cloud Technology (ASX: FCT) has won technology super-aggregator Digital WholeSale Solutions (DWS) as a sales partner in Britain and shares have jumped 13 per cent. FirstWave sells a cyber security platform for cloud content aimed...